11-Nor-9-carboxy-†9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 18, 2013, Pages 6019-6027

  Scheidweiler, Karl B ^a   Himes, Sarah K ^a   Chen, Xiaohong ^b   Liu, Hua Fen ^b   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b AB SCIEX   (United States)

Author keywords

Analytical method; Cannabinoids; Carboxy THC; LCMSMS; Metabolites; Oral fluid

Indexed keywords

ANALYTICAL METHOD; CANNABINOIDS; CARBOXY THC; LC-MSMS; ORAL FLUIDS;

ACETIC ACID; COLUMN CHROMATOGRAPHY; DRUG THERAPY; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; METABOLITES; PH;

MASS SPECTROMETRY;

11 NOR DELTA(9) TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID; 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; BIOLOGICAL MARKER; DRONABINOL; DRUG DERIVATIVE;

CALIBRATION; CHEMISTRY; CONFERENCE PAPER; ELECTROSPRAY MASS SPECTROMETRY; EVALUATION STUDY; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; METHODOLOGY; REPRODUCIBILITY; SALIVA; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CALIBRATION; CHROMATOGRAPHY, LIQUID; DRONABINOL; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

CANNABIS;

EID: 84879795552     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7027-6     Document Type: Conference Paper

References (28)

1. Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27(3):147-159
2. Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910-1931
3. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P (2008) Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol 32(6):393-401
4. Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, De La Torre R (2011) Oral fluid testing: promises and pitfalls. Clin Chem 57(6):805-810
5. Wood M, Laloup M, Ramirez Fernandez Mdel M, Jenkins KM, Young MS, Ramaekers JG, De Boeck G, Samyn N (2005) Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int 150(2-3):227-238
6. Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44. U.S. Department of Health and Human Services, Rockville
7. Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H (1995) Metabolism of delta-9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys. Life Sci 56:2089-2095
8. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80(15):1415-1419
9. Huestis MA, Cone EJ (2004) Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 28(6):394-399
10. Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem 58(4):748-756
11. Milman G, Schwope DM, Gorelick DA, Huestis MA (2012) Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta 413(7-8):765-770
12. Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ (2004) Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 28(7):546-552
13. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ (2005) Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 29(7):607-615
14. Moore C, Coulter C, Uges D, Tuyay J, van der Linde S, van Leeuwen A, Garnier M, Orbita J Jr (2011) Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int 212(1-3):227-230
15. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin Chem 57(8):1127-1136
16. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA (2012) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2012.10.011, epub ahead of print
17. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 56(8):1261-1269
18. Moore C, Coulter C, Rana S, Vincent M, Soares J (2006) Analytical procedure for the determination of the marijuana metabolite 11-nor-delta9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 30(7):409-412
19. Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217(9):1513-1521
20. Day D, Kuntz DJ, Feldman M, Presley L (2006) Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 30(9):645-650
21. Coulter C, Garnier M, Moore C (2012) Analysis of tetrahydrocannabinol and its metabolite, 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry. J Anal Toxicol 36(6):413-417
22. Lee PD, Chang YJ, Lin KL, Chang YZ (2012) Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in oral fluid using isotope dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 402(2):851-859
23. He X, Kozak M, Nimkar S (2012) Ultra-sensitive measurements of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal Chem 84(18):7643-7647
24. Krouwer JS, Rabinowitz R (1984) How to improve estimates of imprecision. Clin Chem 30(2):290-292
25. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75(13):3019-3030
26. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral delta9-tetrahydrocannabinol administration. Clin Chem 57(11):1597-1606
27. Quintela O, Andrenyak DM, Hoggan AM, Crouch DJ (2007) A validated method for the detection of delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9) -tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 31(3):157-164
28. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J (2007) Detection of conjugated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol 31(4):187-194